|
Report No. : |
336854 |
|
Report Date : |
19.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
PHARMACHEMICALS
HANDELS GMBH |
|
|
|
|
Registered Office : |
Spaldingstr 201 D 20097 Hamburg |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Year of Establishment : |
1996 |
|
|
|
|
Legal Form : |
Private limited company |
|
|
|
|
Line of Business : |
|
|
|
|
|
No. of Employees : |
5 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GERMANY - ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, contributed to strong growth and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 5.2% in 2014. The new German government introduced a minimum wage of about $11.60 (8.50 euros) per hour to take effect in 2015. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's total budget deficit - including federal, state, and municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced the deficit to 0.8% in 2011 and in 2012 Germany reached a budget surplus of 0.1%. The budget was essentially in balance in 2014. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016 though the target was already reached in 2012. The German economy suffers from low levels of investment, and a government plan to invest 15 billion euros 2016-18, largely in infrastructure, is intended to spur needed private investment. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela MERKEL announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany plans to replace nuclear power with renewable energy, which accounted for 27.8% of gross electricity consumption in 2014, up from 9% in 2000. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its electricity generating capacity and 46% of its base-load electricity production. Extremely low inflation, caused largely by low global energy prices and a weak euro, are expected to boost German GDP growth in 2015.
|
Source
: CIA |
PHARMACHEMICALS
Handels GmbH
Spaldingstr. 210
D 20097 Hamburg
Telephone:040/2369492
Telefax:
040/2369368
Homepage: www.pharmachemicals-gmbh.de
E-mail:
info@pharmachemicals-gmbh.de
Active
DE183047394
Business relations are permissible.
LEGAL
FORM Private limited company
Date of foundation: 1996
Shareholders'
agreement: 18.09.1996
Registered on: 06.12.1996
Commercial Register: Local court 20355 Hamburg
under: HRB
62976
Share capital: EUR 50,000.00
Shareholder:
Dr. Avraam Sarafidis
Grenzknick 7
D 22043 Hamburg
born: 18.11.1961
Share: EUR 15,000.00
Shareholder:
Eleni Sarafidis
D 20097 Hamburg
born: 11.09.1985
Share: EUR 15,000.00
Shareholder:
Nikolaos Sarafidis
D 20097 Hamburg
born: 06.07.1989
Share: EUR 15,000.00
Shareholder:
Michaela Sarafidis
D 20097 Hamburg
born: 26.06.1958
Share: EUR 5,000.00
Manager:
Dr. Avraam Sarafidis
Grenzknick 7
D 22043 Hamburg
having sole power of representation
born: 18.11.1961
Profession: Chemist
Proxy:
Michaela Sarafidis
D 20097 Hamburg
having sole power of representation
born: 26.06.1958
Proxy:
Eleni Sarafidis
D 20097 Hamburg
having sole power of
representation
born: 11.09.1985
11.07.1997 -
31.12.1998 TRANSPHARMA and CHEMICALS Handels GmbH
Gotenstr. 13
D 20097
Hamburg
Private limited company
Main industrial sector
46461
Wholesale of pharmaceutical goods
46760
Wholesale of other intermediate goods
Within agreed terms
We have no negative information at hand.
Balance sheet year: 2013
Type of ownership: Tenant
Address Spaldingstr.
210
D 20097 Hamburg
Real Estate of: Dr.
Avraam Sarafidis
Type of ownership: unknown
Address Grenzknick
7
D 22043 Hamburg
Land
register documents were not available.
Principal bank
COMMERZBANK, 20454 HAMBURG
Sort. code: 20040000
BIC: COBADEHHXXX
Gross profit or loss:2013 EUR 3,739,459.00
2014 EUR 3,740,000.00
Profit: 2013 EUR 1,549,870.00
further business figures:
Equipment: EUR 4,650.00
Ac/ts receivable: EUR 4,267,220.00
Liabilities: EUR 927,236.00
Employees:
5
- Freelancer:
1
BALANCE SHEETS
Balance sheet ratios 01.01.2013 - 31.12.2013
Equity ratio [%]: 80.71
Liquidity ratio: 10.00
Return on total capital [%]: 21.05
Balance sheet ratios 01.01.2012 - 31.12.2012
Equity ratio [%]: 79.58
Liquidity ratio: 10.00
Return on total capital [%]: 18.33
Balance sheet ratios 01.01.2011 - 31.12.2011
Equity ratio [%]: 73.55
Liquidity ratio: 10.00
Return on total capital [%]: 21.39
Balance sheet ratios 01.01.2010 - 31.12.2010
Equity ratio [%]: 61.84
Liquidity ratio: 10.00
Return on total capital [%]: 20.04
Equity ratio
The
equity ratio indicates the portion of the equity as compared
to
the total capital. The higher the equity ratio, the better the
economic stability (solvency) and thus the
financial autonomy of
a
company.
Liquidity ratio
The
liquidity ratio shows the proportion between adjusted
receivables and net liabilities. The higher
the ratio, the lower
the
company's financial dependancy from external creditors.
Return on total capital
The
return on total capital shows the efficiency and return on
the
total capital employed in the company. The higher the return
on
total capital, the more economically does the company work
with the invested capital.
Type of balance
sheet: Company balance sheet
Financial year: 01.01.2013 - 31.12.2013
ASSETS EUR 7,363,714.66
Fixed assets EUR 84,650.12
Tangible assets EUR 4,650.12
Other tangible assets / fixtures and
fittings EUR 4,650.12
Financial assets EUR 80,000.00
Other / unspecified financial assets
EUR 80,000.00
Current assets EUR 7,248,964.13
Stocks EUR 1,099,029.01
Accounts receivable EUR 4,267,220.36
Liquid means EUR 1,882,714.76
Remaining other assets EUR 30,100.41
Accruals (assets) EUR 30,100.41
LIABILITIES EUR 7,363,714.66
Shareholders' equity EUR 5,887,522.45
Capital
EUR 50,000.00
Subscribed capital (share capital) EUR 50,000.00
Balance sheet profit/loss (+/-) EUR 5,837,522.45
Balance sheet profit / loss EUR 5,837,522.45
Provisions EUR 548,956.45
Liabilities EUR 927,235.76
Other liabilities EUR 0.00
Unspecified other liabilities EUR 0.00
thereof liabilities from social
security EUR 0.00
PROFIT AND LOSS ACCOUNT (cost-summary method)
according to Comm.
Code (HGB)
Gross result (+/-) EUR 3,739,458.96
Staff expenses EUR 886,495.49
Wages and salaries EUR 830,624.62
Social security contributions and
expenses for pension plans and
benefits EUR 55,870.87
Total depreciation EUR 4,815.34
Depreciation on tangible / intangible
asssets (incl. start-up and exp. of
bus. EUR 4,815.34
Other operating expenses EUR 559,020.58
Operating result from continuing
operations EUR 2,289,127.55
Interest result (+/-) EUR -3.24
Interest and similar income EUR 9.68
Interest and similar expenses EUR 12.92
Financial result (+/-) EUR -3.24
Result from ordinary operations (+/-) EUR
2,289,124.31
Income tax / refund of income tax
(+/-)EUR -738,710.47
Other taxes / refund of taxes EUR -543.61
Tax (+/-) EUR -739,254.08
Annual surplus / annual deficit EUR 1,549,870.23
Type of balance
sheet: Company balance sheet
Financial year: 01.01.2012 - 31.12.2012
ASSETS EUR 6,023,544.10
Fixed assets EUR 78,271.12
Tangible assets EUR 8,495.12
Other tangible assets / fixtures and
fittings EUR 8,495.12
Financial assets EUR 69,776.00
Other / unspecified financial assets
EUR 69,776.00
Current assets EUR 5,921,499.11
Stocks EUR 944,778.20
Accounts receivable EUR 3,812,304.77
Other debtors and assets EUR 3,812,304.77
Liquid means EUR 1,164,416.14
Remaining other assets EUR 23,773.87
Accruals (assets) EUR 23,773.87
LIABILITIES EUR 6,023,544.10
Shareholders' equity EUR 4,737,652.22
Capital EUR 50,000.00
Subscribed capital (share capital) EUR 50,000.00
Balance sheet profit/loss (+/-) EUR 4,687,652.22
Balance sheet profit / loss EUR 4,687,652.22
Provisions EUR 323,000.00
Liabilities EUR 962,891.88
thereof total due to shareholders EUR 55,713.77
Other liabilities EUR 962,891.88
Unspecified other liabilities EUR 962,891.88
thereof liabilities from social
security
EUR 1,037.45
PROFIT AND LOSS ACCOUNT (cost-summary method)
according to Comm.
Code (HGB)
Gross result (+/-) EUR 2,972,035.21
Staff expenses EUR 823,074.36
Wages and salaries EUR 767,077.44
Social security contributions and
expenses for pension plans and
benefits EUR 55,996.92
Total depreciation EUR 4,006.05
Depreciation on tangible / intangible
asssets (incl. start-up and exp. of
bus. EUR 4,006.05
Other operating expenses EUR 514,408.70
Operating result from continuing
operations EUR 1,630,546.10
Interest result (+/-) EUR 26.65
Interest and similar income EUR 26.65
Financial result (+/-) EUR 26.65
Result from ordinary operations (+/-) EUR
1,630,572.75
Income tax / refund of income tax
(+/-)EUR -526,344.71
Other taxes / refund of taxes EUR -386.31
Tax (+/-) EUR -526,731.02
Annual surplus / annual deficit
EUR 1,103,841.73
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.65.22 |
|
UK Pound |
1 |
Rs.102.23 |
|
Euro |
1 |
Rs.72.39 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
TRU |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major sections
of this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.